Literature DB >> 9128988

Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperatures.

H Schuldes1, S Bade, J Knobloch, D Jonas.   

Abstract

BACKGROUND: Cisplatin (cis-dichlorodiammineplatinum [II]) is one of the most potent and widely used cytotoxic drugs in cancer therapy. However, in vitro cytotoxicity assays often yield diverging results. Therefore, it is believed by many investigators that cisplatin is not effective in vitro. The authors investigated whether the experimental conditions used could be responsible for the diverging results.
METHODS: In vitro cytotoxicity assays were performed using the original cisplatin solution as distributed by the manufacturer or a 5-fold dilution of this in cell culture medium after storage for 2 weeks or 1 month at various temperatures (room temperature, 4 degrees C, and -20 degrees C).
RESULTS: The original solution of cisplatin retained the full cytotoxic potency for at least 1 month under all storage conditions tested. The highest loss of cytotoxicity resulted from storage of cisplatin in cell culture medium in which a >7-fold increase in the concentration that inhibits 50% occurred after 2 weeks' storage at room temperature. Solutions stored in culture medium at -20 degrees C retained full cytotoxic potency.
CONCLUSIONS: Cisplatin is a potent cytotoxic drug in vitro when stored under appropriate conditions. These findings are of relevance for in vitro studies with cisplatin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128988

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Exposure time versus cytotoxicity for anticancer agents.

Authors:  David M Evans; Jianwen Fang; Thomas Silvers; Rene Delosh; Julie Laudeman; Chad Ogle; Russell Reinhart; Michael Selby; Lori Bowles; John Connelly; Erik Harris; Julia Krushkal; Larry Rubinstein; James H Doroshow; Beverly A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  2019-05-17       Impact factor: 3.333

2.  Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.

Authors:  Ardith W El-Kareh; Rachel E Labes; Timothy W Secomb
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

3.  Effects of solvents on in vitro potencies of platinum compounds.

Authors:  Yong Weon Yi; Insoo Bae
Journal:  DNA Repair (Amst)       Date:  2011-10-05

4.  Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.

Authors:  Nicole C Schmitt; Edwin W Rubel; Neil M Nathanson
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

5.  The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.

Authors:  Sudeshna Mukherjee; Subhra Dash; K Lohitesh; Rajdeep Chowdhury
Journal:  PLoS One       Date:  2017-06-09       Impact factor: 3.240

6.  Fertility preservation in women with ovarian cancer: Finding new pathways: A case-control study.

Authors:  Ali Khodadadian; Yasser Varghaiyan; Emad Babakhanzadeh; Iraj Alipourfard; Saeed Haghi-Daredeh; Amin Ghobadi; Mohsen Hemmati-Dinarvand; Mehrdad Talebi; Nasrin Ghasemi
Journal:  Int J Reprod Biomed       Date:  2021-02-21

7.  In Vitro Activity of Monofunctional Pt-II Complex Based on 8-Aminoquinoline against Human Glioblastoma.

Authors:  Valentina Coccè; Isabella Rimoldi; Giorgio Facchetti; Emilio Ciusani; Giulio Alessandri; Lucia Signorini; Francesca Sisto; Aldo Giannì; Francesca Paino; Augusto Pessina
Journal:  Pharmaceutics       Date:  2021-12-07       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.